tldrdailynews.com logo
Tag

Ozempic

All articles tagged with #ozempic

New Data Links GLP-1 Drugs to Nail Detachment and Hair Loss
health5 days ago

New Data Links GLP-1 Drugs to Nail Detachment and Hair Loss

Two new studies presented at the European Academy of Dermatology and Venereology Congress indicate that users of GLP-1 receptor agonists, such as semaglutide and tirzepatide, experience significantly higher rates of hair loss and nail problems compared to non-users. While the findings show a strong association, experts emphasize that these issues may stem from rapid weight loss and nutritional deficiencies rather than the drugs themselves, and patients should not discontinue treatment without medical advice.

via Gizmodo|
#dermatology#glp-1#health
Neuroscientist warns rapid GLP-1 weight loss may force brain to consume its own tissue
health9 days ago

Neuroscientist warns rapid GLP-1 weight loss may force brain to consume its own tissue

Dr. Tommy Wood, a University of Washington neuroscientist, warns that rapid weight loss from GLP-1 medications like Ozempic and Wegovy can deprive the brain of essential energy. He explains that extreme caloric deficits may force the brain to consume its own white matter, similar to what happens during intense marathon running. While these drugs can improve cognitive health by lowering blood pressure and blood sugar in obese patients, severe under-eating risks long-term cognitive impairment. Wood advises pairing these medications with resistance training and ensuring adequate intake of neuro-nutrients like omega-3s, iron, and B vitamins to protect brain function.

via New York Post|
#brain-health#glp-1-drugs#health
Massachusetts Father’s Blindness Lawsuit Highlights Growing GLP-1 Vision Disputes
health-and-legal9 days ago

Massachusetts Father’s Blindness Lawsuit Highlights Growing GLP-1 Vision Disputes

Edward Gillen, a Massachusetts father and former state highway worker, has joined a wave of over 200 lawsuits alleging that GLP-1 drugs like Ozempic caused permanent blindness. He claims the medication led to non-arteritic anterior ischemic optic neuropathy (NAION), a rare condition described as a 'stroke' of the optic nerve. While Gillen and other plaintiffs argue that manufacturers failed to warn about this risk, Novo Nordisk maintains that the drug has a strong safety profile and that the lawsuits are without merit. Medical experts remain divided, with some noting a potential link while others emphasize the risk is low and unconfirmed.

via Yahoo|
#edward-gillen#glp-1-lawsuits#health-and-legal
Massachusetts Father Sues Novo Nordisk Over Permanent Blindness Linked to Ozempic
health10 days ago

Massachusetts Father Sues Novo Nordisk Over Permanent Blindness Linked to Ozempic

Edward Gillen, a 59-year-old Massachusetts father and former state highway worker, has filed a lawsuit against Novo Nordisk alleging that the diabetes drug Ozempic caused him to go permanently blind. Gillen, who took the medication for approximately a year to manage diabetes, reported sudden vision loss in May 2025 that progressed to total blindness by June 1. Doctors diagnosed him with nonarteritic anterior ischemic optic neuropathy (NAION), a rare condition described as a 'stroke' of the optic nerve. Gillen is part of a growing wave of over 200 lawsuits in federal court against GLP-1 manufacturers, including Novo Nordisk and Eli Lilly, claiming the drugs caused irreversible vision loss without adequate warning. While Gillen’s community is raising funds for his adaptive training, Novo Nordisk maintains that the lawsuits are without merit and that semaglutide has a well-established safety profile.

via New York Post|
#glp-1#health#lawsuit
Neuroscientist warns GLP-1 weight loss drugs may starve brain of vital nutrients
health10 days ago

Neuroscientist warns GLP-1 weight loss drugs may starve brain of vital nutrients

Dr. Tommy Wood, a University of Washington neuroscientist, warns that rapid weight loss from GLP-1 drugs like Ozempic and Wegovy can deprive the brain of essential energy and nutrients. He explains that extreme caloric restriction may force the brain to consume its own tissue, while chronic under-eating reduces critical nutrients like iron, protein, and omega-3 fats. Wood advises pairing these medications with resistance training and ensuring adequate intake of neuro-nutrients to protect cognitive function.

via Fox News|
#brain-health#glp-1-drugs#health
Indian nationals charged in Florida over counterfeit Ozempic smuggling ring
health-and-legal11 days ago

Indian nationals charged in Florida over counterfeit Ozempic smuggling ring

The U.S. Department of Justice unsealed an indictment against two Indian nationals, Swapnadip Roy and Vicky Ramancha, for allegedly smuggling counterfeit Ozempic from China to U.S. distributors. The scheme, which ran from July 2023 to April 2024, continued even after the FDA seized fake units and issued public warnings. Roy was extradited from Italy to face charges in Florida, while Ramancha remains at large. If convicted, both face up to 71 years in prison.

via CNBC|
#counterfeit-drugs#doj#fda
Why Ozempic Results Vary: Biology, Behavior, and Post-Discontinuation Trends
health14 days ago

Why Ozempic Results Vary: Biology, Behavior, and Post-Discontinuation Trends

GLP-1 weight-loss drugs produce highly variable results, with some users losing over 20% of body weight while others see minimal change. Factors include genetics, emotional eating patterns, and diabetes status. A new Cleveland Clinic study indicates that many patients maintain weight loss after stopping medication through alternative treatments.

via timesofindia.indiatimes.com|
#cleveland-clinic#glp-1-drugs#health
GLP-1 Weight-Loss Drugs May Lower Cancer Recurrence by Boosting Immune Response, Expert Says
health15 days ago

GLP-1 Weight-Loss Drugs May Lower Cancer Recurrence by Boosting Immune Response, Expert Says

The American Association for Cancer Research's 2026 report notes that obesity is a major cancer risk factor, prompting interest in whether GLP-1 drugs like Ozempic and Mounjaro can reduce cancer incidence. While retrospective studies suggest lower cancer risk and higher survival rates for GLP-1 users, evidence remains mixed, with some studies showing increased risks for specific cancers like thyroid cancer. Dr. Sai Yendamuri of Roswell Park Comprehensive Cancer Center suggests these drugs may alter the body's immune response to fight cancer cells, potentially lowering recurrence rates in lung cancer and melanoma. However, randomized clinical trials are lacking, and it remains unclear if benefits stem from weight loss or direct immune effects. Future trials will determine if GLP-1s can serve as a preventive mechanism for cancer.

via New York Post|
#cancer-research#glp-1-drugs#health
GLP-1 Users Face 11x Higher Risk of Vomiting Under Anesthesia, UK Study Finds
health15 days ago

GLP-1 Users Face 11x Higher Risk of Vomiting Under Anesthesia, UK Study Finds

A large UK study reveals that patients taking GLP-1 drugs like Ozempic or Mounjaro face an 11-fold higher risk of regurgitation or pulmonary aspiration during surgery compared to non-users. While the absolute risk remains low, the consequences of inhaling stomach contents while unconscious can be fatal. Experts debate whether stopping the medication before surgery is effective, noting that the drugs' long half-lives may mean standard fasting periods are insufficient to clear the stomach.

via ScienceAlert|
#anesthesia#glp-1#health
GLP-1 Makers Face Hundreds of Lawsuits Over Rare Vision Loss
health17 days ago

GLP-1 Makers Face Hundreds of Lawsuits Over Rare Vision Loss

Hundreds of lawsuits have been filed against Novo Nordisk and Eli Lilly, alleging that GLP-1 drugs like Ozempic and Wegovy cause rare, permanent vision loss. The condition, known as NAION, is not listed on U.S. drug labels, though some countries have added warnings. While the FDA investigates the link, drugmakers deny causation, citing mixed research and the condition's low overall risk.

via WESH|
#glp-1-drugs#health#lawsuits